INTRODUCTION: Despite advances in the care of patients with cancer over the last 10 years, cancer remains the second leading cause of death in the United States. Many patients receive aggressive, in-hospital end-of-life care at high cost. There are few data on outcomes after unplanned hospitalization of patients with metastatic cancer. METHODS: In 2000 and 2010, data were collected on admissions, interventions, and survival for patients admitted to an academic inpatient medical oncology service. RESULTS: The 2000 survey included 191 admissions of 151 unique patients. The 2010 survey assessed 149 admissions of 119 patients. Lung, GI, and breast cancers were the most common cancer diagnoses. In the 2010 assessment, pain was the most common chief complaint, accounting for 28%. Although symptoms were the dominant reason for admission in 2010, procedures and imaging were common in both surveys. The median survival of patients after discharge was 4.7 months in 2000 and 3.4 months in 2010. Despite poor survival in this patient population, hospice was recommended in only 23% and 24% of patients in 2000 and 2010, respectively. Seventy percent of patients were discharged home without additional services. CONCLUSION: On the basis of our data, an unscheduled hospitalization for a patient with advanced cancer strongly predicts a median survival of fewer than 6 months. We believe that hospital admission represents an opportunity to commence and/or consolidate appropriate palliative care services and end-of-life care.
INTRODUCTION: Despite advances in the care of patients with cancer over the last 10 years, cancer remains the second leading cause of death in the United States. Many patients receive aggressive, in-hospital end-of-life care at high cost. There are few data on outcomes after unplanned hospitalization of patients with metastatic cancer. METHODS: In 2000 and 2010, data were collected on admissions, interventions, and survival for patients admitted to an academic inpatient medical oncology service. RESULTS: The 2000 survey included 191 admissions of 151 unique patients. The 2010 survey assessed 149 admissions of 119 patients. Lung, GI, and breast cancers were the most common cancer diagnoses. In the 2010 assessment, pain was the most common chief complaint, accounting for 28%. Although symptoms were the dominant reason for admission in 2010, procedures and imaging were common in both surveys. The median survival of patients after discharge was 4.7 months in 2000 and 3.4 months in 2010. Despite poor survival in this patient population, hospice was recommended in only 23% and 24% of patients in 2000 and 2010, respectively. Seventy percent of patients were discharged home without additional services. CONCLUSION: On the basis of our data, an unscheduled hospitalization for a patient with advanced cancer strongly predicts a median survival of fewer than 6 months. We believe that hospital admission represents an opportunity to commence and/or consolidate appropriate palliative care services and end-of-life care.
Authors: Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch Journal: N Engl J Med Date: 2010-08-19 Impact factor: 91.245
Authors: Arif H Kamal; Keith M Swetz; Elise C Carey; Andrea L Cheville; Heshan Liu; Suzanne R Ruegg; Timothy J Moynihan; Jeff A Sloan; Judith S Kaur Journal: J Oncol Pract Date: 2011-01 Impact factor: 3.840
Authors: Monica Beccaro; Massimo Costantini; Paolo Giorgi Rossi; Guido Miccinesi; Maria Grimaldi; Paolo Bruzzi Journal: J Epidemiol Community Health Date: 2006-05 Impact factor: 3.710
Authors: Glenn Gade; Ingrid Venohr; Douglas Conner; Kathleen McGrady; Jeffrey Beane; Robert H Richardson; Marilyn P Williams; Marcia Liberson; Mark Blum; Richard Della Penna Journal: J Palliat Med Date: 2008-03 Impact factor: 2.947
Authors: Thomas J Smith; Sarah Temin; Erin R Alesi; Amy P Abernethy; Tracy A Balboni; Ethan M Basch; Betty R Ferrell; Matt Loscalzo; Diane E Meier; Judith A Paice; Jeffrey M Peppercorn; Mark Somerfield; Ellen Stovall; Jamie H Von Roenn Journal: J Clin Oncol Date: 2012-02-06 Impact factor: 44.544
Authors: Laura C Hanson; Frances Collichio; Stephen A Bernard; William A Wood; Matt Milowsky; Erin Burgess; Crista J Creedle; Summer Cheek; Lydia Chang; Bhisham Chera; Alexandra Fox; Feng-Chang Lin Journal: J Palliat Med Date: 2017-07-24 Impact factor: 2.947
Authors: Bobby Daly; Andrew Hantel; Kristen Wroblewski; Jay S Balachandran; Selina Chow; Rebecca DeBoer; Gini F Fleming; Olwen M Hahn; Justin Kline; Hongtao Liu; Bhakti K Patel; Anshu Verma; Leah J Witt; Mayumi Fukui; Aditi Kumar; Michael D Howell; Blase N Polite Journal: J Oncol Pract Date: 2016-10 Impact factor: 3.840
Authors: Gabriel A Brooks; Thomas A Abrams; Jeffrey A Meyerhardt; Peter C Enzinger; Karen Sommer; Carole K Dalby; Hajime Uno; Joseph O Jacobson; Charles S Fuchs; Deborah Schrag Journal: J Clin Oncol Date: 2014-01-13 Impact factor: 44.544
Authors: Jennifer A Shin; Amanda Parkes; Areej El-Jawahri; Lara Traeger; Helen Knight; Emily R Gallagher; Jennifer S Temel Journal: Palliat Med Date: 2016-03-15 Impact factor: 4.762